Companies/NovAccess Global Inc.

Company profile

NovAccess Global Inc.

OTC: XSNX · Healthcare · Biotechnology

PublicHQ Chesterland, OH · GeaugaCIK 0001039466Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ 46GM —SS 36

v0.1 · 25/100 weight · pillars only

↑ listing tenure, disclosure history · ↓ return on assets, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$2.7M

Employees

Market cap

$6.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02024

Net income-$2.7M-$2.7M2024

Operating income-$901.7k-$901.7k2024

Total assets$62.2k$62.2k2024

Liabilities$10.1M$10.1M2024

Equity-$10.0M-$10.0M2024

Revenue trend

FY2016 – FY2024 · USD

$750.6k

FY16

$1.2M

FY17

$665.0k

FY18

$1.6M

FY19

FY20

FY23

FY24

Revenue by segment

Filed disclosures · FY2019

By product

Commercial94%

Residential5%

Management Fees1%

By geography

Not disclosed.

The read

NovAccess Global Inc. booked $0 in FY2024 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

PAO Group, Inc.——Praxsyn Corporation——Evome Medical Technologies Inc.——Bloomios, Inc.——

Neighbors

Geauga →

Innovest Global, Inc.——

Key facts

CEODwain K. Morris-Irvin

SectorHealthcare

IndustryBiotechnology

HeadquartersChesterland, OH

ExchangeOTC: XSNX

Employees3

IPO date1998-09-21

Latest filings

10-K2026-01-14 10-Q2024-10-31 8-K2024-09-24 8-K2024-08-01 8-K2024-06-04 8-K2024-05-17 10-Q2024-05-15 8-K2024-05-03

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.